No Data
No Data
Is CanSino Biologics (HKG:6185) A Risky Investment?
CanSino Biologics Gets Registration Certificate for Meningitis Vaccine in Indonesia
CanSino Biologics Expands Global Reach With Indonesian Vaccine Approval
Express News | CanSino Biologics Inc - Menhycia Obtains Drug Registration Certificate in Indonesia
CanSino Biologics Begins Trial for Tetanus, Diptheria, Acellular Pertussis Shots
CanSino Biologics Polio Vaccine Trials Gets First Patient Enrollment